EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Exosomes delivering miR-129-5p combined with sorafenib ameliorate hepatocellular carcinoma progression via the KCTD1/HIF-1α/VEGF pathway

Xinyu Zhu, Zhiwei Li, Li Chen, Limin Li, Mi Ouyang, Hao Zhou, Kai Xiao, Ling Lin, Paul K Chu, Chang Zhou, Chengfeng Xun, Liu Yang und 2 weitere

Cellular Oncology · 2025-06 · 48 (3) · 743-760

DOI: 10.1007/s13402-025-01044-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 14.04.2025. Verfasst von Xinyu Zhu und 13 weiteren Autor:innen. Beteiligte Einrichtung: The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Science, Hunan Normal University, Lushan Road N…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Hypoxia-Inducible Factor 1, alpha Subunit, Sorafenib, Liver Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Laboratory Open Fund of Changsha Maternal and Child Hospital, National Natural Science Foundation of China, Key grant of research and development in Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularHypoxia-Inducible Factor 1, alpha SubunitSorafenibLiver NeoplasmsMicroRNAsVascular Endothelial Growth Factor ADisease ProgressionHumansAnimalsSignal TransductionMaleGene Expression Regulation, NeoplasticCell Line, TumorMice, NudeMiceCell ProliferationCell MovementHep G2 CellsMice, Inbred BALB CFemale

Stichwörter der Autor:innen

ExosomeHIF-1αHepatocellular carcinomaKCTD1Sorafenib

Substanzen

Hypoxia-Inducible Factor 1, alpha SubunitSorafenibMicroRNAsVascular Endothelial Growth Factor AMirn129 microRNA, humanHIF1A protein, human

Autor:innen und Institutionen

  • The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Science, Hunan Normal University, Lushan Road No. 14, Changsha, 410081, China.
  • Key Laboratory of Model Animals and Stem Cell Biology in Hunan Province, School of Medicine, Hunan Normal University, Changsha, 410013, China.
  • College of Engineering and Design, Hunan Normal University, Taozihu Road No. 68, Changsha, 410081, China. hncslilimin@hunnu.edu.cn.
  • Department of Neurosurgery, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, China.
  • Department of Hepatobiliary and Pancreatic Surgery, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, China.
  • Department of Physics, Department of Materials Science and Engineering, and Department of Biomedical Engineering, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong, China.

Förderung

  • Key Laboratory Open Fund of Changsha Maternal and Child Hospital
  • National Natural Science Foundation of China
  • Key grant of research and development in Hunan Province
  • Natural Science Foundation in Hunan Province
  • Key project of Hunan Provincial Education Department
  • Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province

Zitieren

APA

Zhu, X., Li, Z., Chen, L., Li, L., Ouyang, M., Zhou, H., Xiao, K., Lin, L., Chu, P. K., Zhou, C., Xun, C., Yang, L., Huang, W., & Ding, X. (2025). Exosomes delivering miR-129-5p combined with sorafenib ameliorate hepatocellular carcinoma progression via the KCTD1/HIF-1α/VEGF pathway. Cellular Oncology, 48(3), 743-760. https://doi.org/10.1007/s13402-025-01044-x

Vancouver

Zhu X, Li Z, Chen L, Li L, Ouyang M, Zhou H, et al. Exosomes delivering miR-129-5p combined with sorafenib ameliorate hepatocellular carcinoma progression via the KCTD1/HIF-1α/VEGF pathway. Cellular Oncology. 2025;48(3):743-760. doi:10.1007/s13402-025-01044-x

BibTeX
@article{Zhu2025,
  author = {Zhu, Xinyu and Li, Zhiwei and Chen, Li and Li, Limin and Ouyang, Mi and Zhou, Hao and Xiao, Kai and Lin, Ling and Chu, Paul K and Zhou, Chang and Xun, Chengfeng and Yang, Liu and Huang, Wenhuan and Ding, Xiaofeng},
  title = {Exosomes delivering miR-129-5p combined with sorafenib ameliorate hepatocellular carcinoma progression via the KCTD1/HIF-1α/VEGF pathway},
  journal = {Cellular Oncology},
  year = {2025},
  volume = {48},
  number = {3},
  pages = {743--760},
  doi = {10.1007/s13402-025-01044-x}
}
Kostenlos starten →